Metraipolis › archive › dc_3f09a7bb34cd

Obinutuzumab treatment for antineutrophil cytoplasmic antibody-associated vasculitis — Europe PMC PMID:42212146

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42212146
DOI
10.3389/fimmu.2026.1787558
License (as archived)
solo-consultazione
Archived
2026-11-02T09:44:50.868Z
SHA-256 of the archived text
72c74a6eca63271b5cba6f7c39c57a61064ea614e45c5204423f7a5f95e6df49
Stable URL of this page
https://metraipolis.com/documento/dc_3f09a7bb34cd

How to cite

Obinutuzumab treatment for antineutrophil cytoplasmic antibody-associated vasculitis — Europe PMC PMID:42212146 — Europe PMC (en), https://europepmc.org/article/MED/42212146 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3f09a7bb34cd (Metraipolis archive dc_3f09a7bb34cd, sha256 72c74a6eca63271b5cba6f7c39c57a61064ea614e45c5204423f7a5f95e6df49)
BibTeX
@misc{dc3f09a7bb34cd,
  title = {Obinutuzumab treatment for antineutrophil cytoplasmic antibody-associated vasculitis — Europe PMC PMID:42212146},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42212146},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3f09a7bb34cd; sha256 72c74a6eca63271b5cba6f7c39c57a61064ea614e45c5204423f7a5f95e6df49},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42212146. Agents can read the archived copy with the MCP tool read_document.